Hemostatic powder TC-325 treatment of malignancy-related upper gastrointestinal bleeds: International registry outcomes.
Mohamed HusseinDurayd AlzoubaidiMichael O'DonnellAlvaro de la SernaPaul BassettIoannis VarbobitisTricia HengeholdJacobo Ortiz Fernandez-SordoJohannes W ReyBu'Hussain HayeeEdward J DespottAlberto MurinoDavid GrahamMelissa LatorreSulleman MoreeaPhillip BogerJason DunnInder MainieDaniel MulladyDayna EarlyKrish RagunathJohn AndersonPradeep BhandariMartin GoetzRalf KiesslichEmmanuel CoronEnrique Rodriguez de SantiagoTamas GondaSeth A GrossLaurence B LovatRehan HaidryPublished in: Journal of gastroenterology and hepatology (2021)
Hemospray achieved high rates of immediate hemostasis, with comparable rebleed rates following treatment of tumor-related upper gastrointestinal bleeds. Hemospray helped in improving transfusion requirements in these patients. This allows for patient stabilization and bridges towards definitive surgery or radiotherapy to treat the underlying tumor.
Keyphrases
- end stage renal disease
- minimally invasive
- ejection fraction
- chronic kidney disease
- newly diagnosed
- early stage
- peritoneal dialysis
- radiation therapy
- squamous cell carcinoma
- case report
- prognostic factors
- acute coronary syndrome
- coronary artery disease
- percutaneous coronary intervention
- sickle cell disease
- replacement therapy
- smoking cessation
- glycemic control